Lelin Hu1, Kaixian Zhang2, Lihong Yao3, Junjie Wang3. 1. Department of Radiation Oncology, Peking University 3rd Hospital Haidian District, Beijing 100191, People's Republic of China ; Department of Medical Immunology, School of Medicine, Anhui University of Science and Technology Huainan 232001, Anhui, China. 2. Department of Oncology, Teng Zhou Central People's Hospital Affiliated to Jining Medical College Teng Zhou 277599, Shandong, China. 3. Department of Radiation Oncology, Peking University 3rd Hospital Haidian District, Beijing 100191, People's Republic of China.
Abstract
OBJECTIVE: Chemokine (C-C motif) ligand 5 (CCL5) has been shown to play an important role in antimycobacterial immune responses. Previous studies have extensively reported that the CCL5 -28C>G gene polymorphism is associated with susceptibility to tuberculosis (TB). However, the results of these studies have been inconsistent. To investigate the relationship between the CCL5 -28C>G and the risk of TB, we performed a meta-analysis. METHODS: We searched articles published before June 6, 2014 from PubMed, CNKI, and Wanfang databases. Data were extracted from all eligible publications independently by two investigators and statistically analyzed. Odds ratios (OR) with 95% confidence intervals (CI) were calculated to assess the strength of the association between CCL5 polymorphism and TB. RESULTS: Four case-control studies including 647 TB cases and 726 controls were involved in the meta-analysis. Our meta-analysis indicated the CCL5 -28C>G gene polymorphism was significantly associated with increased risk of TB (G vs. C: 3.75, 95% CI = 1.76-7.99; GG vs. CC: OR = 30.26, 95% CI = 14.28-64.12). CONCLUSION: Our results suggested that the -28C>G polymorphism is significantly associated with higher TB risk, which is opposite from previously published reports. However, the number of the study is limited, additional well-designed studies are required to elucidate the association between the CCL5 -28C>G gene polymorphism and TB.
OBJECTIVE:Chemokine (C-C motif) ligand 5 (CCL5) has been shown to play an important role in antimycobacterial immune responses. Previous studies have extensively reported that the CCL5 -28C>G gene polymorphism is associated with susceptibility to tuberculosis (TB). However, the results of these studies have been inconsistent. To investigate the relationship between the CCL5 -28C>G and the risk of TB, we performed a meta-analysis. METHODS: We searched articles published before June 6, 2014 from PubMed, CNKI, and Wanfang databases. Data were extracted from all eligible publications independently by two investigators and statistically analyzed. Odds ratios (OR) with 95% confidence intervals (CI) were calculated to assess the strength of the association between CCL5 polymorphism and TB. RESULTS: Four case-control studies including 647 TB cases and 726 controls were involved in the meta-analysis. Our meta-analysis indicated the CCL5 -28C>G gene polymorphism was significantly associated with increased risk of TB (G vs. C: 3.75, 95% CI = 1.76-7.99; GG vs. CC: OR = 30.26, 95% CI = 14.28-64.12). CONCLUSION: Our results suggested that the -28C>G polymorphism is significantly associated with higher TB risk, which is opposite from previously published reports. However, the number of the study is limited, additional well-designed studies are required to elucidate the association between the CCL5 -28C>G gene polymorphism and TB.
Authors: M Sánchez-Castañón; I C Baquero; P Sánchez-Velasco; M-C Fariñas; F Ausín; F Leyva-Cobián; J G Ocejo-Vinyals Journal: Int J Tuberc Lung Dis Date: 2009-04 Impact factor: 2.373
Authors: Jussi J Saukkonen; Beth Bazydlo; Michael Thomas; Robert M Strieter; Joseph Keane; Hardy Kornfeld Journal: Infect Immun Date: 2002-04 Impact factor: 3.441
Authors: S E Jamieson; E N Miller; G F Black; C S Peacock; H J Cordell; J M M Howson; M-A Shaw; D Burgner; W Xu; Z Lins-Lainson; J J Shaw; F Ramos; F Silveira; J M Blackwell Journal: Genes Immun Date: 2004-01 Impact factor: 2.676
Authors: Pedro O Flores-Villanueva; Jorge A Ruiz-Morales; Chang-Hwa Song; Ludmila M Flores; Eun-Kyeong Jo; Marta Montaño; Peter F Barnes; Moises Selman; Julio Granados Journal: J Exp Med Date: 2005-12-13 Impact factor: 14.307